MTOR and metabolic dysfunction-associated steatotic liver disease: KEGG pathway enrichment analysis revealed that the active components of LF exert effects on NAFLD and DM comorbidity primarily through the Wnt, mTOR, and Phospholipase D signaling pathways (Figure 2B, Table S7).